Challenges have been tied to its insurance unit, Aetna, which has struggled with rising medical costs, particularly in its Medicare plans. David Joyner, who recently replaced Karen Lynch as CEO, is focusing on reorganization efforts and improvements at Aetna, which he has described as unacceptable, said the WSJ. Robbins noted that the changes aim to enhance CVS's operational execution and profitability while prioritizing debt reduction to stabilize its balance sheet. He also highlighted the value the new board members bring, saying their networks could help bolster CVS's management at various levels, according to the WSJ. The agreement with Glenview is seen as a step toward rebuilding investor confidence as CVS executes its strategic reset.